Welcome to our dedicated page for BORGWARNER SEC filings (Ticker: BWA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BorgWarner Inc. filings document the regulatory record of an automotive technology supplier with common stock listed on the New York Stock Exchange under BWA and 1.00% Senior Notes due 2031 listed under BWA31. Recent Form 8-K reports cover operating results, financial guidance, dividend declarations, shareholder returns, material events and Regulation FD disclosures tied to company press releases.
Proxy and governance filings describe board matters, executive compensation, shareholder voting matters and equity incentive plan authorizations. The filing record also includes disclosures on capital structure, registered securities, spin-off related matters, legal settlements and accounting items affecting BorgWarner's reported financial position.
Rule 144 notice to sell 15,000 shares of BorgWarner common stock is reported to be executed through Merrill Lynch with an aggregate market value of $589,718.34 and an approximate sale date of 08/12/2025. The filing reports 216,392,876 shares outstanding, so the block to be sold is a very small portion of total shares.
The securities were acquired under the issuer equity compensation plan via vesting of restricted stock units: 10,000 shares vested on 02/08/2019 and 5,000 shares vested on 02/06/2021. The filing also discloses that Stefan Demmerle sold 20,000 shares on 08/04/2025 for gross proceeds of $763,383.17.
The filer affirms, by signing the notice, that they do not know of any material adverse nonpublic information about the issuer not publicly disclosed.
BorgWarner filed a Form 144 reporting a proposed sale of 2,500 common shares to be executed through Charles Schwab on 08/12/2025 with an aggregate market value of $100,025, to be listed on the NYSE. The 2,500 shares equal approximately 0.001155% of the issuer's 216,392,876 shares outstanding, indicating the sale is immaterial to the company’s overall capitalization. The shares were acquired as equity compensation: 1,380 from a restricted stock lapse on 02/28/2020 and 1,120 from a performance stock lapse on 02/05/2025, which together match the 2,500 shares proposed for sale. The filing also discloses two prior dispositions in the past three months totaling 10,000 shares for aggregate proceeds of $354,800. The signer represents no known undisclosed material adverse information.
BorgWarner's Schedule 13G/A shows Victory Capital Management, Inc. beneficially owns 7,798,478 shares of common stock, equal to 3.55% of the class. Victory Capital reports sole voting power over 7,588,779 shares and sole dispositive power over 7,798,478 shares, and classifies itself as an investment adviser (IA). The filing includes a certification that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Reporting person: Isabelle McKenzie (Vice President, officer).
Transaction: On 08/04/2025 Ms. McKenzie sold 5,000 shares of BorgWarner Inc. (BWA) common stock at $37.71 per share.
Holdings after transaction: 58,445 shares. The Form 4 was filed and signed by Miyuki P. Oshima as attorney-in-fact on 08/06/2025.